Management of thymic tumors: A European perspective

Journal of Thoracic Disease

Volumn 6, Issue SUPPL.2, 2014, Pages

  Ruffini, Enrico ^a   Venuta, Federico ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Staging; Surgery; Thymic tumors; Thymoma, thymic carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL EXAMINATION; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; EUROPE; HEALTH CARE SURVEY; HISTOPATHOLOGY; HUMAN; MANAGED CARE; MOLECULARLY TARGETED THERAPY; REVIEW; THYMOMA; THYMUS CANCER; THYMUS SURGERY; TREATMENT OUTCOME;

EID: 84904731475     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2014.04.19     Document Type: Review

References (44)

1. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003;105:546-51.
2. Venuta F, Anile M, Diso D, et al. Thymoma and thymic carcinoma. Eur J Cardiothorac Surg 2010;37:13-25.
3. Chen J, Yang Y, Zhu D, et al. Thymoma with pure red cell aplasia and Good's syndrome. Ann Thorac Surg 2011;91:1620-2.
4. Inoue Y, True LD, Martins RG. Thymic carcinoma associated with paraneoplastic polymyositis. J Clin Oncol 2009;27:e33-4.
5. Azuma Y, Shiga K, Ishii R, et al. Polymyositis with atypical pathological features associated with thymic carcinoma. Intern Med 2009;48:163-8.
6. Benveniste MF, Rosado-de-Christenson ML, SabloffBS, et al. Radiographics 2011;31:1847-61; discussion 1861-3.
7. Ruffini E, Oliaro A, Novero D, et al. Neuroendocrine tumors of the thymus. Thorac Surg Clin 2011;21:13-23, v.
8. Marom EM. Imaging thymoma. J Thorac Oncol 2010;5:S296-303.
9. Marom EM. Advances in thymoma imaging. J Thorac Imaging 2013;28:69-80; quiz 81-3.
10. Sadohara J, Fujimoto K, Müller NL, et al. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radiol 2006;60:70-9.
11. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77:1860-9.
12. Filosso PL, Ruffini E, Lausi PO, et al. Historical perspectives: The evolution of the thymic epithelial tumors staging system. Lung Cancer 2014;83:126-32.
13. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-92.
14. Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994;44:359-67.
15. Rosai J, Sobin L. Histological typing of tumours of the thymus. In: Rosai J, Sobin L. eds. World Health Organization, International classification of tumours. Berlin: Springer, 1999:9-14.
16. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pathology and genetics of tumours of the lung, pleura, thymus and heart. In: Kleihues P, Sobin LH. eds. WHO Classification of tumours. 2nd Edition Lyon: IARC Press, 2004:145-97.
17. Detterbeck F, Youssef S, Ruffini E, et al. A review of prognostic factors in thymic malignancies. J Thorac Oncol 2011;6:S1698-704.
18. Detterbeck FC, Parsons AM. Management of stage I and II thymoma. Thorac Surg Clin 2011;21:59-67, vi-vii.
19. Koppitz H, Rockstroh JK, Schüller H, et al. State-of-theart classification and multimodality treatment of malignant thymoma. Cancer Treat Rev 2012;38:540-8.
20. Kaiser LR. Surgical treatment of thymic epithelial neoplasms. Hematol Oncol Clin North Am 2008;22:475-88.
21. Toker A, Sonett J, Zielinski M, et al. Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol 2011;6:S1739-42.
22. Marulli G, Rea F, MelfiF, et al. Robot-aided thoracoscopic thymectomy for early-stage thymoma: a multicenter European study. J Thorac Cardiovasc Surg 2012;144:1125-30.
23. Rückert JC, Swierzy M, Ismail M. Comparison of robotic and nonrobotic thoracoscopic thymectomy: a cohort study. J Thorac Cardiovasc Surg 2011;141:673-7.
24. Girard N, Mornex F. The role of radiotherapy in the management of thymic tumors. Thorac Surg Clin 2011;21:99-105, vii.
25. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-84; discussion 884-5.
26. Ruffini E, Mancuso M, Oliaro A, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 1997;113:55-63.
27. Forquer JA, Rong N, Fakiris AJ, et al. Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease. Int J Radiat Oncol Biol Phys 2010;76:440-5.
28. Korst RJ, Kansler AL, Christos PJ, et al. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg 2009;87:1641-7.
29. Loehrer PJ Sr, Chen M, Kim K, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 1997;15:3093-9.
30. Girard N, Lal R, Wakelee H, et al. Chemotherapy definitions and policies for thymic malignancies. J Thorac Oncol 2011;6:S1749-55.
31. Wei ML, Kang D, Gu L, et al. Chemotherapy for thymic carcinoma and advanced thymoma in adults. Cochrane Database Syst Rev 2013;8:CD008588.
32. Girard N. Thymic epithelial tumours: from basic principles to individualised treatment strategies. Eur Respir Rev 2013;22:75-87.
33. Girard N. Targeted therapies for thymic malignancies. Thorac Surg Clin 2011;21:115-23, viii.
34. Lamarca A, Moreno V, Feliu J. Thymoma and thymic carcinoma in the target therapies era. Cancer Treat Rev 2013;39:413-20.
35. Giaccone G, Rajan A, Ruijter R, et al. Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas. J Thorac Oncol 2009;4:1270-3.
36. Cimpean AM, Raica M, Encica S, et al. Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus. Ann Anat 2008;190:238-45.
37. Ströbel P, Bargou R, WolffA, et al. Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience. Br J Cancer 2010;103:196-200.
38. Detterbeck F. International thymic malignancies interest group: a way forward. J Thorac Oncol 2010;5:S365-70.
39. Ruffini E, Van Raemdonck D, Detterbeck F, et al. Management of thymic tumors: a survey of current practice among members of the European Society of Thoracic Surgeons. J Thorac Oncol 2011;6:614-23.
40. Endo M, Nakagawa K, Ohde Y, et al. Utility of 18FDGPET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 2008;61:350-5.
41. Inoue A, Tomiyama N, Tatsumi M, et al. (18)F-FDG PET for the evaluation of thymic epithelial tumors: Correlation with the World Health Organization classification in addition to dual-time-point imaging. Eur J Nucl Med Mol Imaging 2009;36:1219-25.
42. Ruffini E, Detterbeck F, Van Raemdonck D, et al. Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg 2014. [Epub ahead of print].
43. Detterbeck FC, Zeeshan A. Thymoma: current diagnosis and treatment. Chin Med J (Engl) 2013;126:2186-91.
44. Tomaszek S, Wigle DA, Keshavjee S, et al. Thymomas: review of current clinical practice. Ann Thorac Surg 2009;87:1973-80.